BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8574157)

  • 1. Sporadic activation of Epstein-Barr virus in thyroid lymphoma.
    Tomita Y; Ohsawa M; Kanno H; Matsuzuka F; Kuma K; Aozasa K
    Leuk Lymphoma; 1995 Sep; 19(1-2):129-34. PubMed ID: 8574157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus.
    Lam KY; Lo CY; Kwong DL; Lee J; Srivastava G
    Am J Clin Pathol; 1999 Aug; 112(2):263-70. PubMed ID: 10439808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan.
    Tomita Y; Ohsawa M; Mishiro Y; Kubo T; Maeshiro N; Kojya S; Noda Y; Aozasa K
    Lab Invest; 1995 Aug; 73(2):190-6. PubMed ID: 7637319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
    Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
    Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No significant association of Epstein-Barr virus infection with invasive breast carcinoma.
    Chu PG; Chang KL; Chen YY; Chen WG; Weiss LM
    Am J Pathol; 2001 Aug; 159(2):571-8. PubMed ID: 11485915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a reservoir of Epstein-Barr virus (EBV) in normal tongue epithelium.
    Miller DR; Heard PL; Cagle MP; DiMaio D; Ench Y; Morrison DG; Eagan PA; Gulley ML; Jenson HB; Moyer MP
    J Oral Pathol Med; 1994 Apr; 23(4):156-60. PubMed ID: 8046652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma.
    Kanno H; Yasunaga Y; Ohsawa M; Taniwaki M; Iuchi K; Naka N; Torikai K; Shimoyama M; Aozasa K
    Int J Cancer; 1996 Jul; 67(1):86-94. PubMed ID: 8690530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
    Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
    Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
    Higgins JP; van de Rijn M; Jones CD; Zehnder JL; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):236-47. PubMed ID: 10941339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant lymphoma of the urethra: report of a case with detection of Epstein-Barr virus genome in the tumour cells.
    Ohsawa M; Mishima K; Suzuki A; Hagino K; Doi J; Aozasa K
    Histopathology; 1994 Jun; 24(6):525-9. PubMed ID: 8063280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
    Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma.
    Homayouni M; Mohammad Arabzadeh SA; Nili F; Razi F; Amoli MM
    Pathol Res Pract; 2017 Jul; 213(7):854-856. PubMed ID: 28554750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.